STEVE ANTOLINE Insider Trading
Get free email notifications about insider trading for STEVE ANTOLINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVE ANTOLINE. STEVE ANTOLINE is a Director in Protea Biosciences Group, Inc. ($PRGB).
Address: 955 HARTMAN RUN ROAD MORGANTOWN 26507 WV
Companies in which STEVE ANTOLINE is an Insider
Protea Biosciences Group, Inc.
Trading Symbol: PRGBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVE ANTOLINE: Director
Holdings: 26,325,894 shares
Current Value: $2,895,848
Latest Transaction: Apr 04 2017
$PRGB Market Capitalization: $13.44M
$PRGB Previous Close: $0.11
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEVE ANTOLINE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 04 2017 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | J | 0.11 | 16,564,248 | 1,863,478 | 42,422,699 | |
Apr 04 2017 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | J | 0.09 | 16,564,248 | 1,490,782 | 42,422,699 | |
Apr 04 2017 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 16,564,248 | 0 | 26,325,894 | 9.8 M to 26.3 M (+169.69 %) |
Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | A | 0.25 | 66,667 | 16,667 | 66,667 | |
Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 165,573 | 0 | 6,319,426 | 6.2 M to 6.3 M (+2.69 %) |
Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Grant | A | 0.00 | 100,000 | 0 | 6,153,853 | 6.1 M to 6.2 M (+1.65 %) |
Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 244,456 | 0 | 6,053,853 | 5.8 M to 6.1 M (+4.21 %) |